Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)-scFc
Emirodatamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1-kappa
Fazpilodemab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1;Kappa;Kappa
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)
Pacanalotamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)-scFc
Pavurutamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3
Izuralimab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1-kappa-[scFv-heavy-lambda]2
Cadonilimab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3
Vudalimab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)
Eluvixtamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)-scFc
Emerfetamab